Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

Thursday’s Trading Day
34.49 -0.30 / -0.86%
As of May 05
Day’s Change
Friday’s Pre-Market   Switch to standard view »
33.20 -1.29 / -3.74%
 
Volume: --
New Valeant CEO Acknowledges "Mistakes" In Drug Prices, Forms Oversight Panel
May 05 / TheStreet.com
Tweets on the Street: Puerto Rico Defaults, Ackman Speaks, Starbucks Iced Out
May 02 / TheStreet.com
Start With Your Own Investing Advice
May 05 / TheStreet.com
My Takeaways and Observations
May 02 / TheStreet.com
Here's Why Horizon Pharma plc's Stock Slumped in April
May 05 / MotleyFool.com
How Buffett Caused Valeant Stock's Latest Tumble
May 02 / MotleyFool.com
Zoetis Shares Fall Despite Beating Estimates and Boosting Outlook
May 04 / TheStreet.com
Cramer Reacts to Berkshire's Amazon, Valeant Comments
May 02 / TheStreet.com
Did One Decision Destroy Sequoia?
May 04 / MotleyFool.com
Valeant Shares Destined For Major Turnaround, Bill Ackman Says
May 02 / TheStreet.com
My Takeaways and Observations
May 04 / TheStreet.com
One Reason Why Valeant (VRX) Stock Is Plummeting Today
May 02 / TheStreet.com
Ackman Defends Valeant From Buffett, Munger Criticism
May 04 / GuruFocus News
My Diagnosis of Valeant Pharmaceuticals
May 02 / TheStreet.com
Valeant Could Decrease Another 50% to 70%
May 04 / TheStreet.com
Slew Of Negative News, Defaults And Failed Mergers Push Futures In The Green
May 02 / Investing Channel
Valeant (VRX) Stock Declines as Chanos Reiterates Short
May 04 / TheStreet.com
It's Scary Down There: Buying at the Lows
May 01 / TheStreet.com
Today's Perilous Reversal Stock: Valeant Pharmaceuticals International (VRX)
May 04 / TheStreet.com
Cramer: The Market Needs New Leadership
Apr 29 / TheStreet.com
Avoid Valeant (Redux)
May 04 / TheStreet.com
Cramer: Buy Valeant for a Trade Ahead of Bill Ackman's Monday TV Appearance
Apr 29 / TheStreet.com
Jim Cramer's 'Mad Money' Recap: 'Sell in May' Is Just a Stupid Limerick
May 03 / TheStreet.com
Government Probes for Valeant; New Board Members Put Forth
Apr 29 / TheStreet.com
Why Vertex Pharmaceuticals, FMC, and Fidelity National Information Services Jumped To...
May 03 / MotleyFool.com
More Squawk From Jim Cramer: Buy Valeant (VRX) Stock on Today's Weakness
Apr 29 / TheStreet.com
What's Behind Valeant Pharmaceuticals Soaring 10% Today?
May 03 / MotleyFool.com
Pre-Market Laggard: Valeant Pharmaceuticals International (VRX)
Apr 29 / TheStreet.com
Valeant Pharmaceuticals Intl. Inc. Jumped 27% in April, But It's Not Out of the Woods
May 03 / MotleyFool.com
Valeant Pharmaceuticals' Mea Culpa May Throw the Entire Industry Under the Bus
Apr 28 / MotleyFool.com
Cramer: Sell in May and Go Away at Your Own Risk
May 03 / TheStreet.com
This Mega-Fund Just Gobbled Up Valeant's Shares -- Should You, Too?
Apr 26 / MotleyFool.com
Price Target Changes: Marvell Technology (MRVL), Valeant (VRX), Anadarko (APC), Illum...
May 03 / Investing Channel
Perrigo's CEO Resigns, Trims 2016 Outlook, Stock Tumbles
Apr 26 / Zacks.com
Valeant Shares Spike as New CEO Joseph Papa Takes Office
May 03 / TheStreet.com
Stock Market News for April 26, 2016
Apr 26 / Zacks.com
Trade-Ideas: Valeant Pharmaceuticals International (VRX) Is Today's "Barbarian At The...
May 03 / TheStreet.com
One Mutual Fund That Valeant Pharmaceuticals International Inc. Took Down With It
Apr 26 / MotleyFool.com
Valeant (VRX) Stock Soars as Papa Assumes CEO Role
May 03 / TheStreet.com
Valeant Pharma (VRX) Names Former Perrigo (PRGO) CEO to Fill Position
Apr 25 / Zacks.com
3 Stocks Improving Performance Of The Drugs Industry
May 03 / TheStreet.com
Why Perrigo Company PLC Ordinary Shares Are Dropping Today
Apr 25 / MotleyFool.com
Take Ackman With a Large Grain of Salt
May 03 / TheStreet.com
The Only Way to Fix Valeant Pharmaceuticals Will Probably Disappoint Investors
Apr 22 / MotleyFool.com
Best Moments From Buffett's Annual Berkshire Shareholder Meeting
May 02 / GuruFocus News